Topic - Incyte Corp.

Incyte said it had followed guidance issued by the U.S. Department of Health and Human Services Office of Inspector General, and that the company “believes that it complied with the HHS-OIG guidance, did not violate the law and did not have any intention to do so.”

Pharma company to pay $12.6M to settle kickback allegations →

Delaware pharma company wins lawsuit over secrets, no money →